Geode Capital Management
CLPT icon

Geode Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Geode Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.06M Sell
741,550
-8,382
-1% -$126K ﹤0.01% 2540
2026
Q2 		$13.4M Buy
749,932
+44,212
+6% +$552K ﹤0.01% 2383
2026
Q1 		$6.42M Buy
705,720
+51,375
+8% +$649K ﹤0.01% 2621
2025
Q4 		$8.95M Sell
654,345
-2,052
-0.3% -$38K ﹤0.01% 2461
2025
Q3 		$14.3M Buy
656,397
+31,597
+5% +$372K ﹤0.01% 2196
2025
Q2 		$7.46M Buy
624,800
+323,429
+107% +$4.07M ﹤0.01% 2530
2025
Q1 		$3.58M Buy
301,371
+17,470
+6% +$272K ﹤0.01% 2822
2024
Q4 		$4.37M Sell
283,901
-3,393
-1% -$43.9K ﹤0.01% 2805
2024
Q3 		$3.22M Buy
287,294
+4,170
+1% +$39.9K ﹤0.01% 2959
2024
Q2 		$1.53M Sell
283,124
-229,909
-45% -$1.33M ﹤0.01% 3184
2024
Q1 		$3.49M Buy
513,033
+23,878
+5% +$167K ﹤0.01% 2881
2023
Q4 		$3.32M Buy
489,155
+35,156
+8% +$199K ﹤0.01% 2901
2023
Q3 		$2.27M Buy
453,999
+26,192
+6% +$156K ﹤0.01% 3030
2023
Q2 		$3.1M Buy
427,807
+205,334
+92% +$1.75M ﹤0.01% 2955
2023
Q1 		$1.88M Buy
222,473
+6,988
+3% +$61.2K ﹤0.01% 3060
2022
Q4 		$1.82M Buy
215,485
+327
+0.2% +$3.1K ﹤0.01% 3086
2022
Q3 		$2.23M Buy
215,158
+43,637
+25% +$575K ﹤0.01% 3045
2022
Q2 		$2.24M Sell
171,521
-144,185
-46% -$1.47M ﹤0.01% 3072
2022
Q1 		$3.29M Buy
315,706
+22,214
+8% +$202K ﹤0.01% 3015
2021
Q4 		$3.29M Buy
293,492
+1,656
+0.6% +$24.8K ﹤0.01% 3124
2021
Q3 		$5.18M Buy
291,836
+16,545
+6% +$310K ﹤0.01% 2895
2021
Q2 		$5.26M Buy
275,291
+159,353
+137% +$3.08M ﹤0.01% 2867
2021
Q1 		$2.45M Buy
115,938
+27,431
+31% +$587K ﹤0.01% 3159
2020
Q4 		$1.41M Buy
88,507
+69,639
+369% +$625K ﹤0.01% 3253
2020
Q3 		$103K Buy
18,868
+8,019
+74% +$35.4K ﹤0.01% 3898
2020
Q2 		$38K Hold
10,849
– – ﹤0.01% 4014
2020
Q1 		$38K Buy
+10,849
New +$53.3K ﹤0.01% 3966

Other funds holding CLPT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Compass Financial Management
Compass Financial Management Tampa, Florida $926M AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management's CLPT Position: Q3 2026 in Review

Geode Capital Management reduced its ClearPoint Neuro (CLPT) stake by 1.1% in Q3 2026, selling an estimated $126K and leaving 741,550 shares worth $9.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Geode Capital Management first reported a position in CLPT in Q1 2020 and has held it in 27 quarters since. The position peaked at $14.3M in Q3 2025. 89 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Geode Capital Management held 741,550 shares of ClearPoint Neuro worth $9.06M as of Q3 2026.
  • Geode Capital Management sold 8,382 ClearPoint Neuro shares in Q3 2026, an estimated $126K.
  • ClearPoint Neuro made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2540 holding.
  • Geode Capital Management first reported a position in ClearPoint Neuro in Q1 2020 and has held it in 27 quarters since.
  • Geode Capital Management's ClearPoint Neuro position peaked at $14.3M in Q3 2025.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.